Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
Sponsor: Crinetics Pharmaceuticals Inc.
Summary
A randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with non-pharmacologically treated acromegaly.
Official title: A Randomized, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Non-pharmacologically Treated Acromegaly (PATHFNDR-2)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
111
Start Date
2021-12-17
Completion Date
2028-01
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
Paltusotine
Paltusotine, tablets, once daily by mouth
Placebo
Placebo, tablets, once daily by mouth
Locations (57)
Crinetics Study Site
Aurora, Colorado, United States
Crinetics Study Site
Boston, Massachusetts, United States
Crinetics Study Site
Columbus, Ohio, United States
Crinetics Study Site
Portland, Oregon, United States
Crinetics Study Site
Philadelphia, Pennsylvania, United States
Crinetics Study Site
Pittsburgh, Pennsylvania, United States
Crinetics Study Site
CABA, Buenos Aires, Argentina
Crinetics Study Site
Buenos Aires, Argentina
Crinetics Study Site
CABA, Argentina
Crinetics Study Site
CABA, Argentina
Crinetics Study Site
Córdoba, Argentina
Crinetics Study Site
Fortaleza, Ceará, Brazil
Crinetics Study Site
Belo Horizonte, Minas Gerais, Brazil
Crinetics Study Site
Curitiba, Paraná, Brazil
Crinetics Study Site
Botucatu, São Paulo, Brazil
Crinetics Study Site
Campinas, São Paulo, Brazil
Crinetics Study Site
Rio de Janeiro, Brazil
Crinetics Study Site
São Paulo, Brazil
Crinetics Study Site
São Paulo, Brazil
Crinetics Study Site
Sofia, Bulgaria
Crinetics Study Site (b)
Beijing, Beijing Municipality, China
Crinetics Study Site
Guangzhou, Guangdong, China
Crinetics Study Site
Shijiazhuang, Hebei, China
Crinetics Study Site
Zhengzhou, Henan, China
Crinetics Study Site
Wuhan, Hubei, China
Crinetics Study Site
Changsha, Hunan, China
Crinetics Study Site
Jinan, Shandong, China
Crinetics Study Site
Xi’an, Shanxi, China
Crinetics Study Site
Chengdu, Sichuan, China
Crinetics Study Site
Hangzhou, Zhejiang, China
Crinetics Study Site
Marseille, France
Crinetics Study Site
Pessac, France
Crinetics Study Site
Toulouse, France
Crinetics Study Site
Aachen, Germany
Crinetics Study Site
Berlin, Germany
Crinetics Study Site
München, Germany
Crinetics Study Site
München, Germany
Crinetics Study Site
Würzburg, Germany
Crinetics Study Site
Athens, Greece
Crinetics Study Site (b)
Athens, Greece
Crinetics Study Site
Thessaloniki, Greece
Crinetics Study Site
Budapest, Hungary
Crinetics Study Site
Budapest, Hungary
Crinetics Study Site
Pécs, Hungary
Crinetics Study Site
Bangalore, Karnataka, India
Crinetics Study Site
Belagavi, Karnataka, India
Crinetics Study Site
Kochi, Kerala, India
Crinetics Study Site
Mumbai, Maharashtra, India
Crinetics Study Site
Chandigarh, India
Crinetics Study Site
Delhi, India
Crinetics Study Site
Petah Tikva, Israel
Crinetics Study Site
Roma, Italy
Crinetics Study Site
Bydgoszcz, Poland
Crinetics Study Site
Poznan, Poland
Crinetics Study Site
Wroclaw, Poland
Crinetics Study Site
Barcelona, Spain
Crinetics Study Site
London, United Kingdom